Broadly Neutralising Antibodies (bNAbs) as the Key to Longer-Lasting COVID-19 Vaccines
A study in Japan has identified bNAbs from long-term COVID-19 patients that can better protect against evolving SARS-CoV-2 strains. COVID-19 started with just one original SARS-CoV-2 variant. Over...